Mumbai: Metropolis Healthcare Limited, a pathology laboratory chain, has announced its approval to acquire Delhi NCR-based Core Diagnostics. Led by Ameera Shah, this acquisition aims to strengthen ...
Metropolis Healthcare Limited, a pathology laboratory chain, has announced the acquisition of Delhi NCR-based Core Diagnostics, a company specialising in advanced cancer testing for Rs 246.8 crores.
CORE Diagnostics, a high-end diagnostics service provider, has announced raising $12 million from Eight Roads Ventures, US-based F-Prime Capital Partners and existing investor Artiman Ventures. Zoya ...
ST. LOUIS, Dec. 4, 2019 /PRNewswire/ -- Canopy Biosciences, LLC announced today the acquisition of Core Diagnostics, a leading CLIA-certified provider of biomarker analysis services for ...
Diagnostic chain Metropolis Healthcare on Monday said it will acquire Core Diagnostics for Rs 247 crore. The company's board has approved the acquisition of 100 per cent stake in Core Diagnostics from ...
On Jan 18, we issued an updated research report on Quest Diagnostics, Inc. DGX. The stock carries a Zacks Rank #3 (Hold). We are optimistic about Quest Diagnostics’ consistent efforts to refocus on ...
Core Diagnostics has received USD 12 million (around Rs 82 crore) funding from various investors including US-based F-Prime Capital Partners. Core Diagnostics has received USD 12 million (around Rs 82 ...
Metropolis Healthcare Limited on Monday announced that its Board of Directors has approved the acquisition of Delhi-NCR headquartered Core Diagnostics. According to the company’s statement, this ...
Seamless reading experience. Save your favourite. Despite advances in AI and ML, there will always be some differences between human and technological execution. A technology driven bot or machine can ...
The healthcare industry can benefit a lot from new technologies such as Big Data, analytics and artificial intelligence. It can, for instance, use Big Data and analytics to gain new insights into life ...
Indian medical startup CORE Diagnostics has entered into a new partnership with leading US-based molecular diagnostics company Paradigm to bring to India the latter’s advanced cancer profiling service ...
Core Diagnostics Pvt Ltd, which provides specialised diagnostics services, said it has raised $12 million (Rs 82 crore) from private equity firm Eight Roads Ventures and US-based F-Prime Capital ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈